Claes, K <br/><br/>
Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G.  [electronic resource] 

 -  Disease markers  Oct 1999 
 - 69-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0278-0240 
<br/><br/><label>Standard No.: </label>10.1155/1999/241046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age of Onset<br/>Alleles<br/>BRCA2 Protein<br/>Breast Neoplasms--epidemiology<br/>DNA Mutational Analysis--methods<br/>Exons--genetics<br/>Female<br/>Founder Effect<br/>Genes, BRCA1<br/>Genetic Counseling<br/>Genetic Predisposition to Disease<br/>Genetic Testing<br/>Haplotypes--genetics<br/>Humans<br/>Microsatellite Repeats<br/>Mutation<br/>Neoplasm Proteins--genetics<br/>Neoplastic Syndromes, Hereditary--epidemiology<br/>Oncogenes<br/>Ovarian Neoplasms--epidemiology<br/>Predictive Value of Tests<br/>RNA Splicing<br/>Risk<br/>Transcription Factors--genetics